Can be harnessed to create 'tools', such as drugs, or other therapies
Naturally occurring peptides
Often cyclic
Feature many disulfide bridges
Have other modifications
These all help to make them less susceptible to proteolytic digestion
A challenge for making peptides for in vivo use is designing similar properties
How to obtain a peptide
Purification from tissue
Genetic engineering
Synthetic chemistry approach
Purification from tissue
Often made difficult by the vanishingly low concentrations of some peptides
May not be what you want
Access to the tissue may be problematic
Genetic engineering
May be incompatible (constituent amino acids, modifications, etc.)
Peptides are often produced non-ribosomally
These are generally hard!
If we want a very specific peptide of particular composition and structure a synthetic chemistry approach may work
Advantages of peptide biosynthesis
Nature uses enzymes for biosynthesis
Regardless of method (ribosomal or non-ribosomal), peptides are built with exquisite control over sequence, stereochemistry, regiochemistry, in presence of other reactive groups, modifications, cyclisation, etc.
And quickly!
Chemical synthesis challenges
Reactivity: right bonds forming, wrong bonds not forming?
Sequence
Speed!
Fidelity; want just a single product
Purification?
Selective modifications?
Cyclisation?
Formation of peptide bonds
1. Linking amino acids together
2. Not a chemically complex process
Peptide synthesis must proceed in order
The amide bonds must be formed in a specific order
In protein synthesis, the order of aminoacids is specified by the mRNA sequence, and assembly is controlled by the ribosome
Peptide bond formation
Not spontaneous under normal conditions
Need a coupling reagent/activator to get an efficient reaction
Reactive groups must be activated
The -OH of the acid is a poor leaving group, making it difficult to directly displace
Formation of peptide bond
1. Amides are usually formed by reaction between amines and acidchlorides/reactive esters
2. Acids are typically converted into an 'activated ester' prior to reaction
Acyl chlorides
Have limited value in peptide coupling, because of danger of hydrolysis, racemisation, cleavage of protectinggroups, and other side reactions
DCC-based activation
Dicyclohexylcarbodiimide is an activator
Incomplete reaction at one stage can lead to formation of an impurity in the next
Rapid reaction rates are essential to synthesize long peptides
Amide bond coupling
Competes with side reactions that deplete one or more of the reagents
Each coupling step is a race between amide bond formation, and undesired reactions
Excess reagents at each step is essential for achieving the rapid coupling rates that are necessary to outpace potential side reactions
The impurities must be laboriously separated during the final purification – this is not easy
Solid-phase peptide synthesis
Synthesis of large peptides chain by sequential addition of amino acids is a long and arduous task
Solution is to couple the growing chain to an insoluble resin on the C-terminal end
After each new residue is added successively at the free amino-terminus, the elongated product is recovered by filtration and readied for the next synthetic step
Wash away excess reactants and contaminants
Because the growing chain is coupled to an insoluble resin bead, the method is called solid-phase peptide synthesis
Polymer provides C-term protection
Solution-phase: a methyl ester protects the carboxyl group during amide bond formation
Solid phase: the polymer particle is the ester protecting group; polystyrene
Cleavage of peptide from polymer
1. The peptide-resin linkage must be stable throughout all the peptide elongation steps
2. But easily cleavable at the end of the synthesis
3. Cleave under strongly acidic conditions
Side chain protection
Reactive side chains (-OH, -NH, -SH, -COOH) must also be protected to prevent side-reactions from occurring
Protecting groups must be chosen carefully to be compatible with peptide synthesis strategy
Use protection to control assembly
1. While the desired coupling reactions proceeds, protect the other functional groups from reaction by blocking
2. For the peptide Leu-Gly, protect the NH2 group of leucine, and the COOH group of glycine
Requirements for protecting groups
The blocking must be removable later under conditions in which the newly formed peptide bonds are stable
No point using e.g. an amide to protect the amine, as difficult to hydrolyse that in the presence of the amide bond trying to form
Must be stable for the entire synthesis
Orthogonal protection/synthesis
A protection strategy allowing the deprotection of functional groups independent of each other
Protect NH2 and CO2H differently, so can be removed under different conditions
Allows modification of either end of the dipeptide at will
Coupling strategy
Use protecting groups that are removable only in acid or base to allow independent modification of the N- and C-termini
SPPS process (using Fmoc protection)
1. Fmoc-amino acid
2. e.g. polystyrene ester solid-phase synthesis
Synthetic methods are amendable to incorporation of modifications at time of synthesis
These methods allow for control of
Sequence
Stereochemistry and regiochemistry
Purification
Speed?
Incorporation of modifications
Modifications that could be incorporated
Phosphorylation
Site-specific incorporation of carbohydrates
Phosphorylated Ser and Thr
Challenging
Phosphate group is decomposed by strong acid and lose with base
Requires careful selection of protecting groups or, include unprotected Ser and Thr and 'globally' post-assembly phosphorylate
Phosphorylated Tyr
Less susceptible to strong acid decomposition and is not at all base labile
Site-specific incorporation of carbohydrates
Require relatively mild conditions for glycopeptide syntheses
Repetitive acid treatments can be detrimental to sugar linkages
General strategies for constructing proteins
Stepwise synthesis: synthesise entire protein one amino acid at a time
Fragment assembly: individual peptide strands are initially constructed, purified, and linked together to make the protein
Directed assembly: get peptide, purify, then non-covalently driven to associate into protein-like structures